Clinical Trial Update: Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing the use of serial FES PET/CT imaging to assess estrogen receptor expression in patients with estrogen receptor-positive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Snippet

Sponsor: University of Washington | Conditions: Estrogen Receptor Positive, Primary or Recurrent Breast Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-02-21